Regimen Education and Messaging in Diabetes (REMinD)

NACompletedINTERVENTIONAL
Enrollment

767

Participants

Timeline

Start Date

January 5, 2018

Primary Completion Date

February 2, 2022

Study Completion Date

November 30, 2022

Conditions
Diabetes Mellitus, Type 2Medication Adherence
Interventions
BEHAVIORAL

UMS Strategy

Patients of providers randomized to the UMS arm will receive study-related educational tools at their primary care visit to support the understanding, regimen consolidation, and use of prescriptions.

BEHAVIORAL

SMS Text Messaging

Patients will receive daily text message reminders about when to take medicines based on UMS intervals.

Trial Locations (2)

10029

Mount Sinai School of Medicine, New York

60611

Northwestern University, Chicago

All Listed Sponsors
collaborator

Icahn School of Medicine at Mount Sinai

OTHER

collaborator

Emory University

OTHER

collaborator

Northwestern Memorial Hospital

OTHER

lead

Northwestern University

OTHER

NCT03185741 - Regimen Education and Messaging in Diabetes (REMinD) | Biotech Hunter | Biotech Hunter